Natural products as IL‐6 inhibitors for inflammatory diseases: Synthetic and SAR perspective
Medicinal Research Reviews · 2024-07 · 44 (4) · 1683-1726
DOI: 10.1002/med.22022 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 02.02.2024. Verfasst von Dipesh S Harmalkar und 6 weiteren Autor:innen. Beteiligte Einrichtung: BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University-Seoul, Goyang, South Korea. Hauptthemen laut MEDLINE: Interleukin-6, Biological Products, Inflammation, Interleukin-6 Inhibitors. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 90 Literaturangaben. Gefördert von: National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT), BK21 FOUR Team and Integrated Research Institute for Drug Development, National Research Foundation of Korea.
Abstract (Originalsprache)
Interleukin‐6 (IL‐6), a pleiotropic cytokine, plays a pivotal role in the pathophysiology of various diseases including diabetes, atherosclerosis, Alzheimer's disease, multiple myeloma, rheumatoid arthritis, and prostate cancer. The signaling pathways associated with IL‐6 offer promising targets for therapeutic interventions in inflammatory diseases and IL‐6‐dependent tumors. Although certain anti‐IL‐6 monoclonal antibodies are currently employed clinically, their usage is hampered by drawbacks such as high cost and potential immunogenicity, limiting their application. Thus, the imperative arises to develop novel small non‐peptide molecules acting as IL‐6 inhibitors. Various natural products derived from diverse sources have been investigated for their potential to inhibit IL‐6 activity. Nevertheless, these natural products remain inadequately explored in terms of their structure‐activity relationships. In response, our review aims to provide syntheses and structure activity perspective of natural IL‐6 inhibitors. The comprehensive amalgamation of information presented in this review holds the potential to serve as a foundation for forthcoming research endeavors by medicinal chemists, facilitating the design of innovative IL‐6 inhibitors to address the complexities of inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University-Seoul, Goyang, South Korea.
- Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, South Korea.
- Department of Chemistry, Government College of Arts, Science & Commerce, Sanquelim, Goa, India.
ORCID-Profile: Dipesh S Harmalkar, Hossam Nada, Kyeong Lee
Förderung
- National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT)
- BK21 FOUR Team and Integrated Research Institute for Drug Development
- National Research Foundation of Korea
Zitieren
APA
Harmalkar, D. S., Sivaraman, A., Nada, H., Lee, J., Kang, H., Choi, Y., & Lee, K. (2024). Natural products as IL‐6 inhibitors for inflammatory diseases: Synthetic and SAR perspective. Medicinal Research Reviews, 44(4), 1683-1726. https://doi.org/10.1002/med.22022
Vancouver
Harmalkar DS, Sivaraman A, Nada H, Lee J, Kang H, Choi Y, et al. Natural products as IL‐6 inhibitors for inflammatory diseases: Synthetic and SAR perspective. Medicinal Research Reviews. 2024;44(4):1683-1726. doi:10.1002/med.22022
BibTeX
@article{Harmalkar2024,
author = {Harmalkar, Dipesh S and Sivaraman, Aneesh and Nada, Hossam and Lee, Joohan and Kang, Hyeseul and Choi, Yongseok and Lee, Kyeong},
title = {Natural products as IL‐6 inhibitors for inflammatory diseases: Synthetic and SAR perspective},
journal = {Medicinal Research Reviews},
year = {2024},
volume = {44},
number = {4},
pages = {1683--1726},
doi = {10.1002/med.22022}
}
EUVIMED